Market Analysis - Glaucoma And Retinal Diseases 2018
Glaucoma is a main source of preventable visual impairment all inclusive. This incessant dynamic optic neuropathy causes irreversible vision misfortune through harm to the optic nerve. There are presently no medications that can straightforwardly keep this harm, and all financially accessible glaucoma treatments concentrate on bringing down lifted intraocular weight (IOP), a known hazard factor for glaucoma improvement and movement. The dispatch of settled measurements mix (FDC) items, which join drugs from these different classes, will keep on being a wellspring of huge development in this market. The glaucoma advertise is going to enter a period of new development with the landing of first-in-class drugs, for example, Aerie's Rhopressa, Bausch and Lomb's Vesneo (latanoprost bunod), and Inotek's trabodenoson into the 7MM amid the conjecture time frame, which will produce extra development in the worldwide glaucoma showcase
- Overview of glaucoma, including the study of disease transmission, etiology, pathophysiology, manifestations, conclusion, and treatment rules.
- Annualized Glaucoma showcase income, yearly cost of treatment and treatment use design information from 2013 and figure for a long time to 2023.-
Key subjects included include marketplace characterization, unmet wishes, R&D and medical trials assessment, overdue level medical trial evaluation and implications for the glaucoma therapeutics marketplace.
- Pipeline evaluation: cognizance on the eight past due-stage pipeline glaucoma drugs discussing emerging tendencies as well as evaluation of in advance segment drugs.
- evaluation of the modern-day and destiny marketplace opposition within the worldwide glaucoma therapeutics marketplace. Insightful evaluation of the important thing enterprise drivers, restraints and challenges. each trend is independently researched to offer qualitative evaluation of its implications.
Glaucoma remedy market: trends and opportunities (2017-2023) studies document that offers an insight into the glaucoma treatment marketplace through the years with a unique consciousness on most important classes- prescribed drugs and devices. The file includes special facts on market size and share by means of sort of drugs in glaucoma treatment area. It also discusses key boom drivers, challenges and traits of the marketplace.
This glaucoma remedy market document covers affords records and facts on the us and Japan under its us of a insurance. Glaucoma remedy bureaucracy a vast portion of the overall eye care market. The marketplace for glaucoma treatment has grown swiftly inside the remaining decade, primarily based on each increasing range of human beings with glaucoma and the advent of new remedies. but, the worldwide glaucoma treatment marketplace is predicted to say no that may be due to price reduction of medicine because of everyday availability of many brands in coming years
For this glaucoma remedy market studies, the glaucoma pharmaceuticals are segmented into lessons particularly prostaglandins analogues (PGAs) and Non PGAs that encompass beta blockers, carbonic anhydrase inhibitors and alpha agonists. PGAS are the most widely prescribed drug magnificence for glaucoma with latanoprost (logo name Xalatan) the maximum usually prescribed drug
Key increase drivers of the market encompass rising getting older population, healthcare fees, clinical insurance and new modern aggregate capsules. The market gamers in medicine as well as gadgets segments are completely special and somewhat very fragmented. Leaders in glaucoma medicine area consist of Pfizer Inc, Alcon Inc. (Novartis), Allergan Inc and Merck and Co, Inc. agencies growing glaucoma drug-delivery gadgets consist of Ocular Therapeutix Inc, QLT Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC, Euclid systems Corp and replenish Inc. In glaucoma laser market, pinnacle marketplace leaders encompass Ellex, Lumenis, Quantel and Lightmed
Tun Hussein on National Eye Hospital
JMC Specialist Eye Centre
International Specialist Eye Centre
Optimax Eye Specialist Centre
Eye Laser Correction
Chew Eye Specialist & Surgery
New Hope Medic
Angeline Eye Specialist & Laser Centre
At Sun Time Optometry
USJ Eye Specialist
Mata Clinic & Optometrist
Subspecialist Eye Associates
KL Eye Specialist Centre
Normah Medical Specialist Centre
Eye Specialist Centre Kuching
Major Associations around the Globe :
American Glaucoma Society
British Columbia Association of Optometrists
American Glaucoma Society
World Glaucoma Association
International Glaucoma Association
Glaucoma Research Society of Canada
National Eye Institute - Glaucoma Information in Spanish
Optometric Glaucoma Society
South East Asia Glaucoma Interest Group (SEAGIG)
World Glaucoma Patient Association
American Optometric Association
Asia-Pacific Glaucoma Society (APGS)
Asia-pacific Association of Cataract and Refractive Surgeon
World Association of Eye Hospitals
International Opticians Association
Association of Malaysian Optometrists (AMO)
Malaysian Association for the Blind
Malaysia Glaucoma Society
Malaysian Pharmaceutical Society
Malaysian Society of Ophthalmology
Malaysian Association for the Blind and Blindness
Association of Vision Science Librarians
The worldwide retinal surgery devices market size become estimated at USD 1.fifty six billion in 2016 and is predicted to develop at a CAGR of seven.8% throughout the forecast period. The marketplace is predominantly pushed by growing prevalence of diabetic retinopathy and other continual retinal eye diseases. Diabetic retinopathy is a primary trouble precipitated in diabetes. Because of which, increasing diabetic population base is predicted to be excessive impact rendering growth motive force for retinal surgery devices marketplace at some point of the forecast period.
As in line with the data published in NCBI studies, patient populace tormented by diabetic retinopathy is predicted to attain 191.zero million by using 2030. In addition, it become predicted that population affected by imaginative and prescient-Threatening Diabetic Retinopathy (VTDR) will reach fifty six. 3 million via 2030. The percentage of blindness on account of diabetic retinopathy changed into determined to be 15% to 17% for developed economies together with the U.S. and Europe, three% to 7% for South-East Asia and Pacific vicinity. For that reason, the aforementioned information exemplifies the unaddressed need and high medical urgency to incorporate retinal surgical operation gadgets, thereby, imparting the market with profitable growth possibilities during the forecast duration.
U.S. retinal surgery devices market by product, 2014 - 2025 (USD Million)
Low charge of compliance and non-adherence to complete therapeutic procedures, formulated to lessen imaginative and prescient loss chance in diabetic retinopathy is also predicted to shift the point of interest closer to surgical options. This affords lengthy-term blessings, thereby, fueling the marketplace growth capacity. Non-compliance with the diabetes vision care recommendations by using the patients had been diagnosed as a complicated and chronic health trouble. Consistent with a research published in NCBI, within the US, one-0.33 of the diabetic patients had been discovered to be unsuccessful in following imaginative and prescient care tips diligently. The situation in developing international locations consisting of India & China, non-adherence has reached to a share exceeding 60%.
An upsurge within the geriatric population base, owning extra susceptible in the direction of developing retinal eye illnesses, is further expected to expand the base for the boom of retinal surgical procedure gadgets market. The aforementioned blessings are in all likelihood to boom the adoption of these gadgets over the coming years.
Regular efforts through healthcare agencies to enhance imaginative and prescient care also are one of the key boom contributing elements accountable to bolster boom and enhance penetration rate of retinal surgical treatment devices all through the forecast period. As an instance, in 2014, the UK countrywide Screening Committee formulated a list of key performance signs for diabetic retinopathy eye screening packages in England, as an initiative to stimulate screening and better ailment control.
the global retinal surgical operation devices marketplace is enormously aggressive in nature. This could be marked by way of implementation of competition sustainability techniques by the key players together with Bausch & Lomb incorporated, IRIDEX business enterprise, Synergetic, Inc., which bills for dominant market proportion. These usinesses cognizance on numerous techniques which include new product improvement projects, geographical expansion, and mergers & acquisitions.
for example, in August 2018, Bausch & Lomb announced the provision of their product, Illuminated Directional Laser Probe inside the U.S. This product launch becomes carried out to in seize greater market share. Similarly, in November 2014, IRIDEX Company acquired an aggressive soft of 350,000 USD by means of government of Zambia for ophthalmology laser gadget permitting IRIDEX business enterprise to faucet rising regional markets.
the global diabetic retinopathy marketplace became worth USD five,934.1 million in 2014 and is anticipated to develop at a CAGR of 6.8% over the forecast length. The growing occurrence of diabetes coupled with growing incidences of blindness because of diabetes is anticipated to propel marketplace boom over the forecast duration. The diabetic retinopathy industry entails retinal screening and choice of treatment line relying at the severity of the condition. Moreover, growing worldwide base of geriatric population is predicted to decorate the applicability of the marketplace, fueling its boom. In keeping with the eye ailment incidence studies organization, 40.3% affected person population inside the U.S. suffers from retinopathy. The growing prevalence as said via the IDF is ready 8%, annually estimating over 590 million humans to accumulate diabetes till 2035, thereby selling the sizable boom of the diabetic retinopathy marketplace all through the forecast length. Financial viability as a result of the 11% worldwide healthcare expenditure in preventive measures and remedy of the sickness is a primary propeller for growing countries to promote the marketplace. But, the increase can be confined due to the disproportion existing between the rate of occurrence of sickness and the to be had professional ophthalmologists.
In keeping with the branch of Assistive and Rehabilitative offerings (DARS), Texas, over 78% cases of the ailment were reported in 2013 that could eventually cause lack of vision. The diabetic organization of the United Kingdom in its 2010 key facts file, expected that annual increase within the variety of cases of blindness because of diabetes in England is over 30.five%. The American basis for the Blind (AFB) in its 2009 file anticipated extra than 20% cases of blindness in people aged extra than 45.
Global diabetic retinopathy market, by type, 2012 - 2022 (USD Million)
Hospitals accounted for the largest share ultimately-use phase in 2016, which can be attributed to the excessive affected person turnaround quantity and common readmissions. Supportive infrastructure facilitates a success surgical tactics, which mandates the adoption of retinal surgery devices, accordingly, resulting in the higher proportion of hospitals.
The developing number of government initiatives targeted at promoting green treatment facilities to generate short effects and enhance average healthcare performance additionally served as key contributing elements. Those factors cumulatively are chargeable for hospitals shooting large share in the long run-use section.
Global retinal surgery devices market share by end-use, 2018 (%)
Segments covered in the report:
This file forecasts revenue boom at worldwide, regional & usa ranges and offers an analysis at the industry trends in every of the sub-segments from 2014 to 2025. For the purpose of this examine, Grand View studies has segmented the worldwide retinal surgical treatment gadgets market on the basis of product, software, quit-use and vicinity:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Microscopic Illumination Equipment
Retinal Laser Equipment
Application Outlook (Revenue, USD Million, 2014 - 2025)
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa